Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction
Respiratory Medicine Nov 28, 2019
Hamazaki N, Kamiya K, Matsuzawa R, et al. - Researchers undertook this single-centre observational study to determine if mortality in patients with heart failure with preserved ejection fraction (HFpEF) can be predicted by respiratory muscle weakness (RMW). This study included consecutive 1,023 heart failure patients [445 in heart failure with reduced ejection fraction (HFrEF) and 578 in HFpEF]. At hospital discharge, respiratory muscle strength was evaluated by measuring maximal inspiratory pressure. All-cause mortality following hospital discharge was assessed as the endpoint. They found that 39% of HFpEF patients developed RMW, which was independently related to poor prognosis. Only in HFpEF but not in HFrEF, RWM had an additive influence on prognosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries